Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes
- 29 September 2009
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 36 (1) , 22-32
Abstract
Although severe cutaneous adverse reactions (SCARs), such as Stevens–Johnson syndrome and toxic epidermal necrolysis, are rare, they are associated with considerable morbidity and mortality. The current knowledge regarding background, differential diagnoses, critical care and implications for inter-hospital emergency medical service (EMS) transport of these patients is discussed. SCAR patients will substantially benefit from early interdisciplinary care and thorough consideration of complications during EMS transport and intensive care treatment.Keywords
This publication has 84 references indexed in Scilit:
- Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine*Critical Care Medicine, 2009
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and IsraelJournal of the American Academy of Dermatology, 2008
- Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR StudyJournal of the American Academy of Dermatology, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysisAnnals of Allergy, Asthma & Immunology, 2006
- Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis*Critical Care Medicine, 2006
- Resuscitation fluid volume and abdominal compartment syndrome in patients with major burnsBurns, 2006
- A qualitative and quantitative analysis of protein loss in human burn woundsBurns, 2005
- Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg)Drugs, 2005
- Toxic epidermal necrolysis (Lyell syndrome)Journal of the American Academy of Dermatology, 1990